1.Src kinase inhibitor PP2 protects rat astrocytes from hypoxia/reoxygenation injury in vitro.
Yuchen GU ; Xuhui TONG ; Li YU ; Hao JIAO ; Binbin YU ; Shuying DONG
Journal of Southern Medical University 2015;35(2):239-243
OBJECTIVETo investigate the effect of Src kinase inhibitor PP2 on hypoxia/reoxygenation (H/R) injury in rat astrocytes in vitro.
METHODSIn vitro cultured rat astrocytes were exposed to hypoxia for 8 h followed by reoxygenation for 24 h with or without pretreatment with PP2 (10 µmol/L) for 24 h before H/R injury. MTT assay and flow cytometry were used to detect the viability and apoptosis of the exposed astrocytes, respectively, and the protein expressions of Src, Bax, and Bcl-2 in the cells were determined using Western blotting.
RESULTSPP2 pretreatment significantly increased the viability and decreased the apoptosis rate of rat astrocytes exposed to H/R injury (P<0.01). Western blotting showed that H/R injury caused increased expression of Src kinase, which was lowered by PP2 pretreatment. The ratio of Bax/bcl-2 in the astrocytes increased after H/R injury, and was significantly decreased by PP2 pretreatment (P<0.01).
CONCLUSIONPP2 protects rat astrocytes from H/R injury possibly by inhibiting the expression of Src kinase and activating the anti-apoptotic mechanisms in the cells.
Animals ; Apoptosis ; Astrocytes ; pathology ; Cell Hypoxia ; Cells, Cultured ; Flow Cytometry ; Pyrimidines ; pharmacology ; Rats ; src-Family Kinases ; antagonists & inhibitors
2.Involvement of Src Family Tyrosine Kinase in Apoptosis of Human Neutrophils Induced by Protozoan Parasite Entamoeba histolytica.
Seobo SIM ; Jae Ran YU ; Young Ah LEE ; Myeong Heon SHIN
The Korean Journal of Parasitology 2010;48(4):285-290
Tyrosine kinases are one of the most important regulators for intracellular signal transduction related to inflammatory responses. However, there are no reports describing the effects of tyrosine kinases on neutrophil apoptosis induced by Entamoeba histolytica. In this study, isolated human neutrophils from peripheral blood were incubated with live trophozoites in the presence or absence of tyrosine kinase inhibitors. Entamoeba-induced receptor shedding of CD16 and PS externalization in neutrophils were inhibited by pre-incubation of neutrophils with the broad-spectrum tyrosine kinase inhibitor genistein or the Src family kinase inhibitor PP2. Entamoeba-induced ROS production was also inhibited by genistein or PP2. Moreover, genistein and PP2 blocked the phosphorylation of ERK and p38 MAPK in neutrophils induced by E. histolytica. These results suggest that Src tyrosine kinases may participate in the signaling event for ROS-dependent activation of MAPKs during neutrophil apoptosis induced by E. histolytica.
*Apoptosis
;
Cells, Cultured
;
Entamoeba histolytica/*immunology/*pathogenicity
;
GPI-Linked Proteins/metabolism
;
Genistein/metabolism
;
Humans
;
Neutrophils/*immunology
;
Protein Kinase Inhibitors/metabolism
;
Pyrimidines/metabolism
;
Reactive Oxygen Species/metabolism
;
Receptors, IgG/metabolism
;
src-Family Kinases/antagonists & inhibitors/*metabolism
3.The role of Src kinase inhibitor ZD6474 on multi-drug resistant K562/A02 cells.
Hong-yun JIA ; Juan LI ; Zhong-ying WANG ; Qiang ZHOU ; Xiao-man WU
Chinese Journal of Hematology 2012;33(3):220-224
OBJECTIVETo investigate the role of Src kinase inhibitor ZD6474 on the growth of multidrug-resistant K562/A02 cells and its regulatory mechanisms.
METHODSThe possible mechanisms of drug-resistance were tested by Western blot. Proliferation assays and cell cycle distribution were analyzed by WST metric analysis. Western blot were used to investigate the mechanisms of antiproliferative activity induced by tyrosine kinase inhibitor ZD6474. The in vivo anti-tumor activity was evaluated in K562, K562/A02 xenografted nude mice by administration of ZD6474 (25 - 100 mg×kg(-1)×d(-1), PO).
RESULTSCompared with parental K562 cells, marked high levels of p-Src and Src expression were detected in K562/A02 cells. WST results showed that the IC(50) values of ZD6474 on K562 and K562/A02 after 48 hours incubation were (1.61 ± 0.07) µmol/L and (3.22 ± 0.21)µmol/L, respectively. ZD6474 caused an accumulation of cells in the G(0)/G(1) fraction and apoptosis by inhibiting the expressions of p-Src and Src kinase. Administration of ZD6474 produced a dose-dependent inhibition of tumor growth. 50 mg/kg ZD6474 produced the growth inhibition rates of 43.7% and 56.3%, respectively in K562 and K562/A02.
CONCLUSIONOur results indicated that inhibiting Src kinase could induce K562/A02 cells apoptosis in vitro and in vivo.
Animals ; Apoptosis ; drug effects ; Cell Cycle ; drug effects ; Cell Proliferation ; drug effects ; Drug Resistance, Multiple ; drug effects ; Drug Resistance, Neoplasm ; drug effects ; Female ; Humans ; K562 Cells ; Mice ; Mice, Inbred BALB C ; Piperidines ; pharmacology ; Quinazolines ; pharmacology ; src-Family Kinases ; antagonists & inhibitors
4.Src family kinases affect the expression of Nav1.1 in spiral ganglion neurons.
Qingjiao ZENG ; Huiying CHEN ; Jiping SU
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2014;28(11):789-792
OBJECTIVE:
To investigated the effects of Src family kinases on the expression of mRNA and protein of Nav1.1 in spiral ganglion neurons.
METHOD:
RT-PCR and Western blot techniques respectively explored the level of expression of mRNA and protein of Nav1.1 in spiral ganglion neurons by Src family kinases inhibitor.
RESULT:
An application of the inhibitor of Src family kinases which was PP2 (10 micromol/L) and SU6656 (2 micromol/L) gived rise to the mRNA decreasing to 26% +/- 0.8% and 36% +/- 1.5% respectively (P < 0.05), and protein reducing to 39% +/- 12.5% and 53% +/- 1.7% severally (P < 0.05).
CONCLUSION
Administration of the inhibitor of Src family kinases could decrease the expression of mRNA and protein of Nav1.1 in spiral ganglion neurons.
Animals
;
Indoles
;
pharmacology
;
Male
;
NAV1.1 Voltage-Gated Sodium Channel
;
metabolism
;
Neurons
;
metabolism
;
Pyrimidines
;
pharmacology
;
Rats
;
Rats, Sprague-Dawley
;
Spiral Ganglion
;
cytology
;
Sulfonamides
;
pharmacology
;
src-Family Kinases
;
antagonists & inhibitors
;
metabolism
5.The design, synthesis and anticancer activity of 4-heteroarylamino-3-cyanoquinolines as dual inhibitors of c-Src and iNOS.
Xin CAO ; Qi-dong YOU ; Zhi-yu LI ; Qing-long GUO ; Yong YANG ; Jing SHANG ; Ming YAN ; Ji-wang CHEN ; Meng-ling CHEN
Acta Pharmaceutica Sinica 2009;44(3):288-295
Because c-Src and iNOS are key regulatory enzymes in tumorigenesis, a new series of 4-heterocycle amine-3-quinolinecarbonitriles as potent dual inhibitors of both enzymes were designed, synthesized and evaluated as multiple targets agents in cancer therapy. All compounds were evaluated by two related enzyme inhibition assays and an anti-proliferation assay in vitro. The results showed that most compounds inhibited c-Src and iNOS well. The best compound 33 inhibited both enzymes with the IC50 values of 0.0484 micromol x L(-1) and 34.5 micromol x (-1), respectively. Some of the compounds also showed moderate anti-proliferation activities at 10 micromol x L(-1) against colon cancer HT-29 and liver cancer HepG2 cell lines.
Aniline Compounds
;
chemical synthesis
;
chemistry
;
pharmacology
;
Antineoplastic Agents
;
chemical synthesis
;
chemistry
;
pharmacology
;
Cell Line, Tumor
;
Cell Proliferation
;
drug effects
;
Drug Delivery Systems
;
Drug Design
;
Humans
;
Nitric Oxide Synthase Type II
;
antagonists & inhibitors
;
metabolism
;
Protein-Tyrosine Kinases
;
antagonists & inhibitors
;
metabolism
;
Quinolines
;
chemical synthesis
;
chemistry
;
pharmacology
;
src-Family Kinases
6.Signaling pathway for 2,3,7,8-tetrachlorodibenzo- p-dioxin-induced TNF-alpha production in differentiated THP-1 human macrophages.
Hyeon Joo CHEON ; Young Seok WOO ; Ji Young LEE ; Hee Sook KIM ; Hyun Jin KIM ; Sungwon CHO ; Nam Hee WON ; Jeongwon SOHN
Experimental & Molecular Medicine 2007;39(4):524-534
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD), a prototypic halogenated aromatic hydrocarbon (HAH), is known as one of the most potent toxicants. At least a part of its toxic effects appears to be derived from its ability to induce TNF-alpha production. However, the signaling pathway of TCDD that leads to TNF-alpha expression has not been elucidated. In this study, we investigated the signaling mechanism of TCDD-induced TNF-alpha expression in PMA-differentiated THP-1 macrophages. TCDD induced both mRNA and protein expression of TNF-alpha in a dose- and time-dependent manner. Alpha-Naphthoflavone (NF), an aryl hydrocarbon receptor (AhR) inhibitor, prevented the TCDD-induced expression of TNF-alpha at both mRNA and protein levels. Genistein, a protein tyrosine kinase (PTK) inhibitor, and PD153035, an EGFR inhibitor, also blocked the increase of TNF-alpha expression by TCDD, indicating the role of EGFR in TCDD-induced TNF-alpha expression. On the other hand, PP2, a c-Src specific inhibitor, did not affect TCDD-induced TNF-alpha expression. EGFR phosphorylation was detected as early as 5 min after TCDD treatment. TCDD-induced EGFR activation was AhR-dependent since co-treatment with alpha-NF prevented it. ERK was found to be a downstream effector of EGFR activation in the signaling pathway leading to TNF-alpha production after TCDD stimulation. Activation of ERK was observed from 30 min after TCDD treatment. PD98059, an inhibitor of the MEK-ERK pathway, completely prevented the TNF-alpha mRNA and protein expression induced by TCDD, whereas inhibitors of JNK and p38 MAPK had no effect. PD153035, an EGFR inhibitor, as well as alpha-NF significantly reduced ERK phosphorylation, suggesting that ERK activation by TCDD was mediated by both EGFR and AhR. These results indicate that TNF-alpha production by TCDD in differentiated THP-1 macrophages is AhR-dependent and involves activation of EGFR and ERK, but not c-Src, JNK, nor p38 MAPK. A signaling pathway is proposed where TCDD induces sequential activation of AhR, EGFR and ERK, leading to the increased expression of TNF-alpha.
Animals
;
Benzoflavones/pharmacology
;
Cell Differentiation
;
Cell Line, Tumor
;
Enzyme Activation
;
Genistein/pharmacology
;
Hazardous Substances/*toxicity
;
Humans
;
MAP Kinase Signaling System/drug effects/physiology
;
Macrophages/*metabolism
;
Mice
;
Phosphorylation
;
Pyrimidines/pharmacology
;
Quinazolines/pharmacology
;
RNA, Messenger/metabolism
;
Receptor, Epidermal Growth Factor/antagonists & inhibitors/metabolism
;
Receptors, Aryl Hydrocarbon/antagonists & inhibitors
;
Signal Transduction
;
Tetrachlorodibenzodioxin/*toxicity
;
Tumor Necrosis Factor-alpha/*biosynthesis
;
src-Family Kinases/antagonists & inhibitors/metabolism
7.Functional involvement of src and focal adhesion kinase in a CD99 splice variant-induced motility of human breast cancer cells..
Hyuk Joon LEE ; Eun Sook KIM ; Bok Eun JEE ; Jang Hee HAHN ; Kyu Hyoung HAN ; Kyeong Cheon JUNG ; Seong Hoe PARK ; Han Soo LEE
Experimental & Molecular Medicine 2002;34(3):177-183
Earlier report showed that expression of a splice variant of CD99 transmembrane protein increases invasive ability of human breast cancer cells. Cell motility was also significantly enhanced by the CD99 splice variant expression. In an effort to identify the cellular components that mediate a signal transduction pathway triggered by the CD99 splice variant, known signal path inhibitors were examined for their effects on the motility of the CD99 splice variant-transfected MDA-MB-231 breast cancer cells. Phenylarsine oxide, an inhibitor of phosphatase specific for focal adhesion kinase, and PP1, an inhibitor of src kinase family, significantly suppressed motility of the cells. Among different types of src transfectant clones generated, kinase-negative mutant src transfectant cells were 80% less motile than the mock cells transfected with an empty-vector, while v-src and c-src transfectants exhibited cell motility levels at or slightly above the mock transfectant. These results suggest that src and focal adhesion kinase mediate the intracellular signaling pathway of a CD99 splice variant for the induction of motility of human breast cancer cells.
Antigens, CD/*genetics
;
Arsenicals/pharmacology
;
Breast Neoplasms/*enzymology/genetics/*pathology
;
Cell Adhesion Molecules/*genetics
;
Cell Movement/drug effects
;
Gene Expression
;
Protein-Tyrosine Kinase/antagonists & inhibitors/*metabolism
;
Pyrazoles/pharmacology
;
Pyrimidines/pharmacology
;
Signal Transduction/drug effects
;
Transfection
;
Tumor Cells, Cultured
;
src-Family Kinases/antagonists & inhibitors/*metabolism
8.FAK/c-Src signaling pathway mediates the expression of cell surface HSP90 in cultured human prostate cancer cells and its association with their invasive capability.
Xue-guang LIU ; Ye GUO ; Zuo-qin YAN ; Mu-yi GUO ; Zhi-gang ZHANG ; Chang-an GUO
Chinese Journal of Oncology 2011;33(5):340-344
OBJECTIVETo investigate the expression of heat shock protein 90 (HSP90) on the cell surface of highly invasive human prostate cancer cells PC3 and its possible molecular mechanisms of its effect on cell invasion through analyzing FAK/Src signaling pathway.
METHODSThe expression of cell surface HSP90 on PC3 cells was studied by immunofluorescence staining and surface biotinylation assay respectively. A specific HSP90 antibody was used to inhibit the cell surface HSP90. In vitro cell invasion was assessed by modified Boyden chambers. Phosphorylated FAK on tyr 397, 576, 577 and 925, and phosphorylated c-Src on tyr 416 were examined by Western blot assay. The association between FAK and c-Src was analyzed by immunoprecipitation. The effects of FAK knockdown by siRNA or Src kinases inhibitor PP2, with or without anti-HSP90 antibody, on PC3 cell invasion were also evaluated.
RESULTSA pool of HSP90 was detected on the cell surface of PC3 cells. A specific HSP90 antibody significantly retarded tumor cell invasion. Concomitant with this finding, targeting cell surface HSP90 significantly inhibited the phosphorylations of FAK and c-Src, and also the interactions between FAK and c-Src. FAK knockdown or PP2 dramatically suppressed cell invasion, however, anti-HSP90 antibody didn't further inhibit cell invasion.
CONCLUSIONSCell surface HSP90 promotes human prostate cancer cell invasion through a FAK/c-Src signaling, with may be a novel therapeutic target against metastatic tumors.
Antibodies ; pharmacology ; Cell Line, Tumor ; Cell Membrane ; metabolism ; Focal Adhesion Protein-Tyrosine Kinases ; genetics ; metabolism ; Gene Knockdown Techniques ; HSP90 Heat-Shock Proteins ; immunology ; metabolism ; Humans ; Male ; Neoplasm Invasiveness ; Phosphorylation ; Prostatic Neoplasms ; metabolism ; pathology ; Pyrimidines ; pharmacology ; RNA, Small Interfering ; genetics ; Signal Transduction ; Transfection ; src-Family Kinases ; antagonists & inhibitors ; metabolism
9.Molecular mechanisms for survival regulation of chronic myeloid leukemia stem cells.
Protein & Cell 2013;4(3):186-196
Studies on chronic myeloid leukemia (CML) have served as a paradigm for cancer research and therapy. These studies involve the identification of the first cancer-associated chromosomal abnormality and the subsequent development of tyrosine kinase inhibitors (TKIs) that inhibit BCR-ABL kinase activity in CML. It becomes clear that leukemia stem cells (LSCs) in CML which are resistant to TKIs, and eradication of LSCs appears to be extremely difficult. Therefore, one of the major issues in current CML biology is to understand the biology of LSCs and to investigate why LSCs are insensitive to TKI monotherapy for developing curative therapeutic strategies. Studies from our group and others have revealed that CML LSCs form a hierarchy similar to that seen in normal hematopoiesis, in which a rare stem cell population with limitless self-renewal potential gives rise to progenies that lack such potential. LSCs also possess biological features that are different from those of normal hematopoietic stem cells (HSCs) and are critical for their malignant characteristics. In this review, we summarize the latest progress in CML field, and attempt to understand the molecular mechanisms of survival regulation of LSCs.
Animals
;
DNA-Binding Proteins
;
genetics
;
metabolism
;
Fusion Proteins, bcr-abl
;
antagonists & inhibitors
;
metabolism
;
Humans
;
Hypoxia-Inducible Factor 1
;
metabolism
;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
;
drug therapy
;
metabolism
;
pathology
;
Lipid Metabolism
;
Neoplastic Stem Cells
;
drug effects
;
metabolism
;
Protein Kinase Inhibitors
;
pharmacology
;
therapeutic use
;
Proto-Oncogene Proteins c-bcl-6
;
src-Family Kinases
;
metabolism
10.betaig-h3 triggers signaling pathways mediating adhesion and migration of vascular smooth muscle cells through alphavbeta5 integrin.
Byung Heon LEE ; Jong Sup BAE ; Rang Woon PARK ; Jung Eun KIM ; Jae Yong PARK ; In San KIM
Experimental & Molecular Medicine 2006;38(2):153-161
Adhesion and migration of vascular smooth muscle cells (VSMCs) play an important role in the pathogenesis of atherosclerosis. These processes involve the interaction of VSMCs with extracellular matrix proteins. Here, we investigated integrin isoforms and signaling pathways mediating the adhesion and migration of VSMCs on betaig-h3, a transforming growth factor (TGF)-beta-inducible extracellular matrix protein that is elevated in atherosclerotic plaques. Adhesion assays showed that the alphavbeta5 integrin is a functional receptor for the adhesion of aortic VSMCs to betaig-h3. An YH18 motif containing amino acids between 563 and 580 of betaig-h3 was an essential motif for the adhesion and growth of VSMCs. Interaction between the YH18 motif and the alphavbeta5 integrin was responsible for the migration of VSMCs on betaig-h3. Inhibitors of phosphatidylinositide 3-kinase, extracellular signal-regulated kinase (ERK), and Src kinase reduced the adhesion and migration of VSMCs on betaig-h3. betaig-h3 triggered phosphorylation and activation of AKT, ERK, focal adhesion kinase, and paxillin mediating the adhesion and migration of VSMCs. Taken together, these results suggest that betaig-h3 and alphavbeta5 integrin play a role in the adhesion and migration of VSMCs during the pathogenesis of atherosclerosis.
src-Family Kinases/antagonists & inhibitors
;
Transforming Growth Factor beta/genetics/*physiology
;
Signal Transduction/*physiology
;
Receptors, Vitronectin/genetics/*physiology
;
Protein-Tyrosine Kinases/antagonists & inhibitors
;
Paxillin/metabolism
;
Myocytes, Smooth Muscle/drug effects/metabolism
;
Muscle, Smooth, Vascular/cytology/drug effects/*metabolism
;
Morpholines/pharmacology
;
Molecular Sequence Data
;
Integrins/genetics/*physiology
;
Humans
;
Flavonoids/pharmacology
;
Extracellular Signal-Regulated MAP Kinases/antagonists & inhibitors
;
Extracellular Matrix Proteins/genetics/*physiology
;
Enzyme Inhibitors/pharmacology
;
Chromones/pharmacology
;
Cells, Cultured
;
Cell Movement/*physiology
;
Cell Adhesion/physiology
;
Animals
;
Amino Acid Sequence
;
Amino Acid Motifs/genetics
;
1-Phosphatidylinositol 3-Kinase/antagonists & inhibitors